Reglan and Tardive Dyskinesia Litigation

Searcy Denney filed a lawsuit on January 4, 2011 in the coordinated proceedings pending in Philadelphia against a number of drug companies who were involved in the manufacture and sale of the brand name drug Reglan as well as metoclopramide, its generic equivalent.

This latest filing was on behalf of a disabled deputy sheriff who formerly resided in Central Florida.  This client was prescribed Reglan and metoclopramide for feeding problems following an automobile accident.  After ingesting the drugs for about a year, he developed serious neurological problems and was diagnosed with tardive dyskinesia, a movement disorder which is associated with long-term use of these drugs.

Several thousand cases are expected to be filed prior to the two-year anniversary of the FDA Safety Alert that was issued in February of 2009 warning patients and their doctors that use of Reglan and metoclopramide for more than 3 months was associated with a significantly increased risk of developing tardive dyskinesia and other debilitating movement disorders.